Radioactive iodine therapy does not improve cancer-specific survival in Hürthle cell carcinoma of the thyroid

X Wang, X Zheng, J Zhu, Z Li… - The Journal of Clinical …, 2022 - academic.oup.com
Context It is unclear whether radioactive iodine (RAI) therapy could improve cancer-specific
survival (CSS) in patients with Hürthle cell carcinoma (HCC) of the thyroid. Objective To …
被引用次数：9 相关文章

Radioactive Iodine Therapy Does not Improve Cancer-specific Survival in Hürthle Cell Carcinoma of the Thyroid

X Wang, X Zheng, J Zhu, Z Li… - The Journal of clinical …, 2022 - pubmed.ncbi.nlm.nih.gov
Context It is unclear whether radioactive iodine (RAI) therapy could improve cancer-specific
survival (CSS) in patients with Hürthle cell carcinoma (HCC) of the thyroid. Objective To …

Radioactive Iodine Therapy Does not Improve Cancer-specific Survival in Hurthle Cell Carcinoma of the Thyroid.

X Wang, X Zheng, J Zhu, Z Li, T Wei - Journal of Clinical Endocrinology …, 2022 - go.gale.com
Context: It is unclear whether radioactive iodine (RAI) therapy could improve cancer-specific
survival (CSS) in patients with Hurthle cell carcinoma (HCC) of the thyroid. Objective: To …

Radioactive Iodine Therapy Does not Improve Cancer-specific Survival in Hürthle Cell Carcinoma of the Thyroid.

X Wang, X Zheng, J Zhu, Z Li… - Journal of Clinical …, 2022 - search.ebscohost.com
Context: It is unclear whether radioactive iodine (RAI) therapy could improve cancer-specific
survival (CSS) in patients with Hürthle cell carcinoma (HCC) of the thyroid. Objective: To …

Radioactive Iodine Therapy Does not Improve Cancer-specific Survival in Hürthle Cell Carcinoma of the Thyroid

X Wang, X Zheng, J Zhu, Z Li… - The Journal of Clinical …, 2022 - academic.oup.com
Context It is unclear whether radioactive iodine (RAI) therapy could improve cancer-specific
survival (CSS) in patients with Hürthle cell carcinoma (HCC) of the thyroid. Objective To …

Radioactive Iodine Therapy Does not Improve Cancer-specific Survival in Hürthle Cell Carcinoma of the Thyroid.

X Wang, X Zheng, J Zhu, Z Li, T Wei - The Journal of Clinical …, 2022 - europepmc.org
Methods HCC patients who underwent total thyroidectomy (TT) were identified from the
Surveillance, Epidemiology, and End Results (SEER) database between 2000 and 2018 …
[PDF] archive.org

[PDF][PDF] Radioactive iodine therapy does not improve cancer-specific survival in Hürthle cell carcinoma of the thyroid

X Wang, X Zheng, J Zhu, Z Li, T Wei - 2022 - scholar.archive.org
Background: It is unclear whether radioactive iodine (RAI) therapy could improve
cancerspecific survival (CSS) in patients with hürthle cell carcinoma (HCC) of thyroid …